Yuki Hirose

Closest collaborators

The 25 strongest of 51 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Toshifumi Wakai · 10 shared papers, 2015–2025 · strength 1.16
   • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
   • Paper [Long-Term Survival after Liver and Pulmonary Metastasectomy Following Chemotherapy for Metastatic Pancreatic Ductal Ad… PMID 38247096↗
   • Paper Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.16584↗
2. Atsushi Oba · 5 shared papers, 2023–2025 · strength 0.87
   • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
   • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
   • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗
3. Yu Takahashi · 5 shared papers, 2023–2025 · strength 0.87
   • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
   • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
   • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗
4. Naoki Sasahira · 5 shared papers, 2023–2025 · strength 0.87
   • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
   • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
   • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗
5. Masato Ozaka · 5 shared papers, 2012–2025 · strength 0.76
   • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
   • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
   • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗
6. Aya Maekawa · 4 shared papers, 2024–2025 · strength 0.74
   • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
   • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
   • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗
7. Kojiro Omiya · 4 shared papers, 2024–2025 · strength 0.74
   • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
   • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
   • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗
8. Hiromichi Ito · 4 shared papers, 2024–2025 · strength 0.74
   • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
   • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
   • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗
9. Kazuyasu Takizawa · 7 shared papers, 2015–2024 · strength 0.71
   • Paper [Long-Term Survival after Liver and Pulmonary Metastasectomy Following Chemotherapy for Metastatic Pancreatic Ductal Ad… PMID 38247096↗
   • Paper Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.16584↗
   • Paper [A Case of Long-Term Survival after Resection of Pancreatic Ductal Adenocarcinoma with Para-Aortic Lymph Node Metastasi… PMID 35045474↗
10. Takashi Sasaki · 3 shared papers, 2024–2025 · strength 0.53
    • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
    • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗
    • Paper Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2024.10.001↗
11. Yoshihiro Ono · 3 shared papers, 2024–2025 · strength 0.53
    • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
    • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗
    • Paper Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2024.10.001↗
12. Yosuke Inoue · 3 shared papers, 2024–2025 · strength 0.53
    • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
    • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗
    • Paper Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2024.10.001↗
13. Manabu Takamatsu · 3 shared papers, 2023–2025 · strength 0.49
    • Paper Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. DOI 10.1016/j.ejso.2025.109635↗
    • Paper Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2024.10.001↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
14. Hiroki Nagaro · 3 shared papers, 2020–2023 · strength 0.37
    • Paper Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.16584↗
    • Paper [A Case of Long-Term Survival after Resection of Pancreatic Ductal Adenocarcinoma with Para-Aortic Lymph Node Metastasi… PMID 35045474↗
    • Paper [A Case of Umbilical Metastasis from Pancreatic Cancer after Surgery]. PMID 33468977↗
15. Yosuke Inoue · 2 shared papers, 2023–2025 · strength 0.34
    • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
16. Kizuki Yuza · 5 shared papers, 2015–2020 · strength 0.33
    • Paper [A Case of Umbilical Metastasis from Pancreatic Cancer after Surgery]. PMID 33468977↗
    • Paper Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression. DOI 10.1016/j.jss.2018.06.019↗
    • Paper [A Case of Long-Term Survival after Reoperation for Neck Lymph Node Metastasis Occurring Seven Years after Pancreaticod… PMID 30692448↗
17. Hirosuke Ishikawa · 3 shared papers, 2016–2024 · strength 0.32
    • Paper [Long-Term Survival after Liver and Pulmonary Metastasectomy Following Chemotherapy for Metastatic Pancreatic Ductal Ad… PMID 38247096↗
    • Paper [A Case of Umbilical Metastasis from Pancreatic Cancer after Surgery]. PMID 33468977↗
    • Paper [Long-Term Survival after Reoperation for Lung Metastasis of Resected Pancreatic Adenocarcinoma - A Case Report]. PMID 28133268↗
18. Takuya Ando · 3 shared papers, 2016–2024 · strength 0.30
    • Paper [Long-Term Survival after Liver and Pulmonary Metastasectomy Following Chemotherapy for Metastatic Pancreatic Ductal Ad… PMID 38247096↗
    • Paper [A Case of Long-Term Survival after Reoperation for Neck Lymph Node Metastasis Occurring Seven Years after Pancreaticod… PMID 30692448↗
    • Paper [Long-Term Survival after Reoperation for Lung Metastasis of Resected Pancreatic Adenocarcinoma - A Case Report]. PMID 28133268↗
19. Tsuyoshi Takeda · 2 shared papers, 2023–2024 · strength 0.29
    • Paper Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2024.10.001↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
20. Tatsunori Suzuki · 2 shared papers, 2023–2024 · strength 0.29
    • Paper Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2024.10.001↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
21. Tsuyoshi Hamada · 2 shared papers, 2023–2024 · strength 0.29
    • Paper Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2024.10.001↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
22. Yoshihiro Ono · 1 shared paper, 2025 · strength 0.21
    • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
23. Takafumi Mie · 1 shared paper, 2025 · strength 0.21
    • Paper Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal compa… DOI 10.1093/bjsopen/zraf026↗
24. Keisuke Aizawa · 1 shared paper, 2024 · strength 0.18
    • Paper [Long-Term Survival after Liver and Pulmonary Metastasectomy Following Chemotherapy for Metastatic Pancreatic Ductal Ad… PMID 38247096↗
25. Akio Saiura · 1 shared paper, 2024 · strength 0.17
    • Paper A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of mult… DOI 10.1093/bjs/znad417↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.